Inter Pharma Public : Board Resolution of Omitted Dividend Payment, Extension of Increasing Capital under General Mandate, Changing the Objectives of Using the IPOs Proceed and Scheduling of 2022 Annual General Meeting of Shareholders (Revised)
March 09, 2022 at 11:21 am IST
Share
Date/Time
09 Mar 2022 12:35:58
Headline
Board Resolution of Omitted Dividend Payment, Extension of Increasing Capital under General Mandate, Changing the Objectives of Using the IPOs Proceed and Scheduling of 2022 Annual General Meeting of Shareholders (Revised)
Symbol
IP
Source
IP
Full Detailed News
Schedule of Shareholders' meeting
Subject : Schedule of Annual General Meeting of
Shareholders
Date of Board resolution : 24-Feb-2022
Shareholder's meeting date : 25-Apr-2022
Beginning time of meeting (h:mm) : 14 : 00
Record date for the right to attend the : 18-Mar-2022
meeting
Ex-meeting date : 17-Mar-2022
Significant agenda item :
- Capital increase
- Omitted dividend payment
Venue of the meeting : via electronic channel (E-AGM)
______________________________________________________________________
Increasing Capital
Subject : Issuance of Additional Shares Under
a General Mandate
Date of Board resolution : 24-Feb-2022
Number of additional common shares : 38,839,959
(shares)
Total of additional shares (shares) : 38,839,959
Par value (baht per share) : 0.50
Type of allocated securities : Common shares
Allocated to : All Common shares' shareholders
Number of allotted shares (shares) : 10,000,000
% of Paid-Up capital as of capital : 3.36
increase BOD resolution date
Allocated to : Private placement (PP)
Number of allotted shares (shares) : 28,839,959
% of Paid-Up capital as of capital : 9.68
increase BOD resolution date
Total shares allocated to Private : 28,839,959
Placement (Shares)
______________________________________________________________________
Dividend payment / Omitted dividend payment
Subject : Omitted dividend payment
Date of Board resolution : 24-Feb-2022
Omitted dividend payment from :
Operating period from 01-Jan-2021 to 31-Dec-2021
______________________________________________________________________
This announcement was prepared and disseminated by listed company or issuer
through the electronic system which is provided for the purpose of dissemination
of the information and related documents of listed company or issuer to the
Stock Exchange of Thailand only. The Stock Exchange of Thailand has no
responsibility for the correctness and completeness of any statements, figures,
reports or opinions contained in this announcement, and has no liability for any
losses and damages in any cases. In case you have any inquiries or
clarification regarding this announcement, please directly contact listed
company or issuer who made this announcement.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Inter Pharma pcl published this content on 09 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2022 05:50:06 UTC.
Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.
Inter Pharma Public : Board Resolution of Omitted Dividend Payment, Extension of Increasing Capital under General Mandate, Changing the Objectives of Using the IPOs Proceed and Scheduling of 2022 Annual General Meeting of Shareholders (Revised)